IL10 and neoplasm: Specifically, GBMs can recruit immunosuppressive cells, such as myeloid cells, to the tumor microenvironment (TME) that can release anti-inflammatory cytokines such as IL-10, leading to T cell exhaustion and immunosuppression [6].